Image-guided spine intervention leads to back pain relief
Results of a study by Greek researchers suggest that percutaneous disc decompression, a newly developed outpatient procedure for herniated vertebral discs, has better long-term effects than conservative therapy.
Results of a study by Greek researchers suggest that percutaneous disc decompression, a newly developed outpatient procedure for herniated vertebral discs, has better long-term effects than conservative therapy. They released findings at the 2009 RSNA meeting.
Percutaneous disc decompression involves inserting a needle into a herniated disc and removing tissue under an imaging guidance system. The procedure, which is done under local anesthetic, is minimally invasive and takes 15 to 60 minutes, depending on the number of discs being treated.
“This is for patients who do not have a motor deficit. They can walk normally, but they're in pain,” said Dr. Alexis Kelekis, an assistant professor of interventional radiology at the University of Athens.
The study consisted of two groups with 31 patients each, all of whom had a history of unsuccessful medical treatment for back or leg pain. One group was randomly assigned to undergo the interventional treatment, which Kelekis described as slightly painful. The other group underwent rigorous conservative therapy, which included physiotherapy and anti-inflammatory drugs. There were no previous differences between the two groups.
Patients who were chosen to participate had clinical symptoms that were concordant with their herniated discs. Patients in both groups reported positive results after three months. Those who underwent the percutaneous disc treatment continued to report decreased pain at 12- and 24-month follow-up. Those under rigorous conservative therapy, however, reported increased pain and decreased mobility after 12 months. Their negative symptoms increased through the 24-month period.
“The effect of the drugs lasts for a while, but slowly the pain comes back. You have to retake the drugs and restart the cycle,” Kelekis said.
According to Kelekis, patients who underwent the percutaneous disc treatment had a slower curve in the beginning, but its effect was sustained over the 24-month follow-up period. While some patients had immediate positive results, the complete effect took approximately three to six months.
“In a way we're imitating what nature will do in the following years by mechanically degenerating those discs,” Kelekis said.
Kelekis stressed the importance of talking to the patient about both the procedure itself and other relevant clinical information.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
